Comparable stake leader
Lagoda Investment Management, L.P.
SEC ownership of VOLITIONRX LTD
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000093314.
Disclosed value leader
Eight Corp Ltd
Comparable rows
46/50
Latest evidence
31 Mar 2026
- Public ticker
- VNRX on NYSE
- Parsed ownership sources
- 13F, 13D/G, and 3/4/5
- Largest SEC-reported holder
- Lagoda Investment Management, L.P.
- Latest 13D/G holder
- Lagoda Investment Management, L.P.
- Latest parsed ownership date
- 31 Mar 2026
- Issuer CIK
- 0000093314
- Issuer location
- Henderson, NV
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of VOLITIONRX LTD (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lagoda Investment Managem...
Disclosed value leader
Eight Corp Ltd
Comparable rows
46/50
Latest evidence
31 Mar 2026
13F
13D/G
3/4/5
Lead comparable stake: 11%
4 rows are not safely comparable across share classes.
13D/G row: Lagoda Investment Management, L.P.
Showing 1-8 of 50 holder rows.
Quick read
Lagoda Investment Management, L.P. leads the comparable SEC ownership view at 11%.
46 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lagoda Investment Management, L.P.'s linked filing trail.
Comparable ownership
Top 5
Lagoda Investment Management, L.P.
11%
ARMISTICE CAPITAL, LLC
5%
Rodney Gerard Rootsaert
0.8%
Terig Hughes
0.43%
Jacob Vincent Micallef
0.42%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. |
13F
13D/G
Company
|
11%
from 13D/G
|
$3,262,098
16,149,000 shares
|
— | 31 Mar 2026 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$1,612,409
6,449,635 shares
|
-$732,698 | 31 Dec 2025 |
| Rodney Gerard Rootsaert |
3/4/5
Secretary
|
0.8%
|
$307,610
1,281,711 shares
|
— | 17 Mar 2026 |
| Terig Hughes |
3/4/5
Chief Financial Officer
|
0.43%
|
$171,242
684,970 shares
|
— | 26 Feb 2026 |
| Jacob Vincent Micallef |
3/4/5
Chief Scientific Officer
|
0.42%
|
$159,669
665,292 shares
|
— | 17 Mar 2026 |
| Jasmine Kway |
3/4/5
CEO - Singapore Volition
|
0.27%
|
$107,253
429,014 shares
|
— | 26 Feb 2026 |
| Nicholas Plummer |
3/4/5
GC - Volition Diagnostics
|
0.26%
|
$97,744
407,267 shares
|
— | 17 Mar 2026 |
| Salvatore Thomas Butera |
3/4/5
CEO - Volition Veterinary
|
0.24%
|
$95,901
375,203 shares
|
— | 22 Jan 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$253,914.
Buys
$253,914
Insiders: 3
Sells
$0
Insiders: 0
Net
+$253,914
Shares: +457,979
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 457,979
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 289,229 | 0 | $146,542 | $0 | +$146,542 |
| 9-12 | 168,750 | 0 | $107,372 | $0 | +$107,372 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 23 reporting-owner rows connected to VOLITIONRX LTD. Open a relationship link for the CIK-to-CIK filing trail.
Rows
23
Largest Forms 3/4/5 holder
Eight Corp Ltd
Net 12M change
+$253,915
Latest report
17 Mar 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Eight Corp Ltd | 10%+ Owner | $20,785,825 | Mixed | 02 Jan 2024 | ||
| Martin Charles Faulkes | Executive Director, Director | $1,739,852 | Mixed | 24 Jan 2024 | ||
| Cameron John Reynolds | President and CEO, Director | $1,039,334 | +$130,358 | +14% | Mixed | 26 Feb 2026 |
| Guy Archibald Innes | Director | $829,492 | +$99,038 | +14% | Mixed | 26 Feb 2026 |
| Timothy I. Still | Director | $415,467 | +$24,519 | +6.3% | Mixed | 22 Jan 2026 |
| Edward Futcher | Director | $362,242 | Mixed | 24 Jan 2024 | ||
| Rodney Gerard Rootsaert | Secretary | $307,610 | Mixed | 17 Mar 2026 | ||
| Terig Hughes | Chief Financial Officer | $171,242 | Mixed | 26 Feb 2026 | ||
| Gaetan Michel | Chief Operating Officer | $166,371 | Mixed | 04 Oct 2025 | ||
| Jacob Vincent Micallef | Chief Scientific Officer | $159,669 | Mixed | 17 Mar 2026 | ||
| Jasmine Kway | CEO - Singapore Volition | $107,253 | Mixed | 26 Feb 2026 | ||
| Nicholas Plummer | GC - Volition Diagnostics | $97,744 | Mixed | 17 Mar 2026 | ||
| Salvatore Thomas Butera | CEO - Volition Veterinary | $95,901 | Mixed | 22 Jan 2026 | ||
| Gael Forterre | Chief Commercial Officer | $88,521 | Mixed | 17 Mar 2026 | ||
| Ann-Louise Batchelor | Group Chief Marketing Officer | $88,369 | Mixed | 26 Feb 2026 | ||
| Kim Nguyen | Director | $84,093 | Mixed | 26 Feb 2026 | ||
| Alan Colman | Director | $65,782 | Mixed | 22 Jan 2026 | ||
| Andrew Retter | Chief Medical Officer | $63,610 | Mixed | 01 Nov 2025 | ||
| Ethel Rubin | Director | $63,237 | Mixed | 26 Feb 2026 | ||
| Jason Bradley Terrell MD | Chief Medical Officer | $27,550 | Mixed | 03 Aug 2022 |
Recent insider transactions for VOLITIONRX LTD
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Gael Forterre | VNRX | Common Stock | Tax liability | -1.56% | -5,251 | 331,338 | 17 Mar 2026 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Tax liability | -1.42% | -3,948 | 273,993 | 17 Mar 2026 | Direct | ||
| Jacob Vincent Micallef | VNRX | Common Stock | Tax liability | -0.92% | -5,310 | 572,179 | 17 Mar 2026 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Tax liability | -1.69% | -7,003 | 407,267 | 17 Mar 2026 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Tax liability | -1.18% | -3,321 | 277,941 | 01 Mar 2026 | Direct | ||
| Gael Forterre | VNRX | Common Stock | Tax liability | -0.67% | -2,283 | 336,589 | 01 Mar 2026 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Tax liability | -1.4% | -5,867 | 414,270 | 01 Mar 2026 | Direct | ||
| Gael Forterre | VNRX | Common Stock | Award | 78.5% | 149,000 | 338,872 | 26 Feb 2026 | Direct | ||
| Ethel Rubin | VNRX | Common Stock | Award | 237.5% | 178,000 | 252,948 | 26 Feb 2026 | Direct | ||
| Cameron John Reynolds | VNRX | Common Stock | Award | 18.5% | 486,000 | 3,115,547 | 26 Feb 2026 | Direct | ||
| Ann-Louise Batchelor | VNRX | Common Stock | Award | 78% | 142,000 | 324,072 | 26 Feb 2026 | Direct | ||
| Terig Hughes | VNRX | Common Stock | Award | 41.8% | 202,000 | 684,970 | 26 Feb 2026 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Award | 73.3% | 119,000 | 281,262 | 26 Feb 2026 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Award | 80.2% | 187,000 | 420,137 | 26 Feb 2026 | Direct | ||
| Kim Nguyen | VNRX | Common Stock | Award | 139.3% | 178,000 | 305,816 | 26 Feb 2026 | Direct | ||
| Jasmine Kway | VNRX | Common Stock | Award | 70.4% | 173,000 | 418,614 | 26 Feb 2026 | Direct | ||
| Jacob Vincent Micallef | VNRX | Common Stock | Award | 34.8% | 149,000 | 577,489 | 26 Feb 2026 | Direct | ||
| Guy Archibald Innes | VNRX | Common Stock | Award | 16.6% | 178,000 | 1,252,967 | 26 Feb 2026 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Tax liability | -2.36% | -5,647 | 233,137 | 01 Feb 2026 | Direct | ||
| Gael Forterre | VNRX | Common Stock | Tax liability | -1.05% | -2,010 | 189,872 | 01 Feb 2026 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Tax liability | -1.93% | -3,196 | 162,262 | 01 Feb 2026 | Direct | ||
| Ethel Rubin | VNRX | Common Stock | Award | 19.1% | 12,000 | 74,948 | 22 Jan 2026 | Direct | ||
| Ann-Louise Batchelor | VNRX | Common Stock | Award | 22.9% | 33,900 | 182,072 | 22 Jan 2026 | Direct | ||
| Mickie Henshall | VNRX | Common Stock | Award | 37.3% | 12,000 | 44,206 | 22 Jan 2026 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Award | 23% | 44,700 | 238,784 | 22 Jan 2026 | Direct | ||
| Kim Nguyen | VNRX | Common Stock | Award | 10.4% | 12,000 | 127,816 | 22 Jan 2026 | Direct | ||
| Gael Forterre | VNRX | Common Stock | Award | 24.8% | 38,100 | 191,882 | 22 Jan 2026 | Direct | ||
| Terig Hughes | VNRX | Common Stock | Award | 11.3% | 49,200 | 482,970 | 22 Jan 2026 | Direct | ||
| Salvatore Thomas Butera | VNRX | Common Stock | Award | 16.6% | 53,400 | 375,203 | 22 Jan 2026 | Direct | ||
| Jasmine Kway | VNRX | Common Stock | Award | 20.6% | 42,000 | 245,614 | 22 Jan 2026 | Direct | ||
| Phillip Barnes | VNRX | Common Stock | Award | 21.7% | 12,000 | 67,368 | 22 Jan 2026 | Direct | ||
| Jacob Vincent Micallef | VNRX | Common Stock | Award | 9.01% | 35,400 | 428,489 | 22 Jan 2026 | Direct | ||
| Guy Archibald Innes | VNRX | Common Stock | Award | 1.13% | 12,000 | 1,074,967 | 22 Jan 2026 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Award | 20.6% | 28,200 | 165,458 | 22 Jan 2026 | Direct | ||
| Alan Colman | VNRX | Common Stock | Award | 4.89% | 12,000 | 257,364 | 22 Jan 2026 | Direct | ||
| Cameron John Reynolds | VNRX | Common Stock | Award | 2.92% | 74,700 | 2,629,547 | 22 Jan 2026 | Direct | ||
| Timothy I. Still | VNRX | Common Stock | Award | 5.86% | 90,000 | 1,625,458 | 22 Jan 2026 | Direct | ||
| Cameron John Reynolds | VNRX | Common Stock | Purchase | 0.79% | $7,000 | $0.3500 | 20,000 | 2,554,847 | 17 Nov 2025 | Direct |
| Andrew Retter | VNRX | Common Stock | Tax liability | -3.04% | -4,588 | 146,568 | 01 Nov 2025 | Direct | ||
| Nicholas Plummer | VNRX | Common Stock | Tax liability | -2.83% | -5,647 | 194,084 | 01 Nov 2025 | Direct | ||
| Gael Forterre | VNRX | Common Stock | Tax liability | -1.13% | -1,753 | 153,782 | 01 Nov 2025 | Direct | ||
| Salvatore Thomas Butera | VNRX | Common Stock | Tax liability | -1.42% | -4,648 | 321,803 | 01 Nov 2025 | Direct | ||
| Rodney Gerard Rootsaert | VNRX | Common Stock | Tax liability | -2.28% | -3,197 | 137,258 | 01 Nov 2025 | Direct | ||
| Cameron John Reynolds | VNRX | Common Stock | Purchase | 4.54% | $56,100 | $0.5100 | 110,000 | 2,534,847 | 14 Oct 2025 | Direct |
| Cameron John Reynolds | VNRX | Warrant (Right to Buy) | Purchase | 110,000 | 110,000 | 14 Oct 2025 | Direct | |||
| Guy Archibald Innes | VNRX | Common Stock | Purchase | 9.95% | $49,038 | $0.5100 | 96,153 | 1,062,967 | 14 Oct 2025 | Direct |
| Guy Archibald Innes | VNRX | Warrant (Right to Buy) | Purchase | 96,153 | 96,153 | 14 Oct 2025 | Direct | |||
| Timothy I. Still | VNRX | Common Stock | Purchase | 3.23% | $24,519 | $0.5100 | 48,076 | 1,535,458 | 14 Oct 2025 | Direct |
| Timothy I. Still | VNRX | Warrant (Right to Buy) | Purchase | 48,076 | 48,076 | 14 Oct 2025 | Direct | |||
| Ann-Louise Batchelor | VNRX | Common Stock | Tax liability | -3.96% | -6,110 | 148,172 | 04 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.